Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/13/2025

MCAS and Hormonal Influences

Introduction to Hormonal Triggers

  • The American Academy of Allergy, Asthma, and Immunology (AAAAI) explicitly identifies hormonal fluctuations as one of several reported triggers that can precipitate mast cell activation episodes in MCAS patients, alongside other triggers such as hot water, alcohol, drugs, stress, exercise, infection, and physical stimuli 1
  • The AAAAI recommends examining whether biomarker levels correlate with hormonal changes during symptomatic episodes, as the connection between specific hormonal triggers and mast cell activation is generally inconclusive except in rare monogenic disorders 1

Mechanistic Considerations

  • The influence of hormones on mast cells likely occurs through multiple pathways, as mast cells express various G protein-coupled receptors that could potentially respond to hormonal signals 2 3

Diagnostic Approach

  • When evaluating patients who report symptom patterns correlating with hormonal cycles, document temporal relationships between hormonal changes and MCAS symptom episodes affecting at least 2 organ systems 1
  • Measure mast cell mediators (such as tryptase, N-methylhistamine, 11β-PGF2α, LTE4) at baseline and during acute episodes that coincide with suspected hormonal triggers 1 4
  • Look for the characteristic pattern of episodic rather than chronic symptoms, as persistent symptoms should direct you toward alternative diagnoses 2 5

Diagnostic Requirements

  • The diagnosis of MCAS requires all three standard criteria: episodic symptoms affecting ≥2 organ systems, documented acute increases in mast cell mediators during symptomatic episodes, and clinical response to mast cell-targeted therapies 1 4

Clinical Pitfalls

  • Do not diagnose MCAS based solely on chronic symptoms that correlate with hormonal cycles without documented episodic multi-system involvement and laboratory confirmation 6 4

Management Implications

  • If hormonal fluctuations are identified as a consistent trigger in a patient with confirmed MCAS, consider prophylactic escalation of mast cell-targeted therapy during predictable hormonal changes 4